Exec Director, Asset Team Leader

Gilead Sciences(1 month ago)

HybridFull TimeExecutive$302,005 - $390,830Commercial and Development

About this role

The Gilead Asset Team Leader (GATL) - Inflammation is an enterprise-level leader responsible for shaping asset vision and strategic direction across multiple indications and drug combinations. Reporting jointly to Commercial and Development Therapeutic Area Heads, the GATL aligns cross-functional stakeholders across development, manufacturing, and commercialization. The role focuses on lifecycle planning and enterprise-level decision-making to ensure optimal program execution.

View Original Listing

Required Skills

Asset Leadership
Cross-Functional
Strategic Planning
Lifecycle Management
Governance
Team Leadership
Stakeholder Engagement
Decision Making
Program Management
Communication

Qualifications

Bachelor’s Degree
PhD
MD
MBA

About Gilead Sciences

gilead.com

Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.

View more jobs at Gilead Sciences →